Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ducray

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic CharacteristicsP Mazzocco, C Barthélémy, G Kaloshi, et al.
Neurology|January 14, 2009
alpha-Internexin expression identifies 1p19q codeleted gliomasF Ducray, E Crinière, A Idbaih, et al.
Neurology|January 28, 2009
TP53 codon 72 polymorphism is associated with age at onset of glioblastomaS El Hallani, F Ducray, A Idbaih, et al.
Revue Neurologique|March 4, 2014
Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, FranceN Badaoui, D Meyronet, S Cartalat-Carel, et al.
Journal of Neuro-Oncology|August 20, 2013
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapyF Ducray, G Kaloshi, C Houillier, et al.
Revue Neurologique|June 19, 2019
Combined analysis of MGMT methylation and dynamic-susceptibility-contrast MRI for the distinction between early and pseudo-progression in glioblastoma patientsA Bani-Sadr, L P Berner, M Barritault, et al.
Neurology|April 30, 2010
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2M Labussière, A Idbaih, X-W Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2021
The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approachesP Billard, C Guerriau, C Carpentier, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2019
Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma-a randomised multicentre trial (ASTER trial). An ANOCEF studyR Ursu, L Thomas, D Psimaras, et al.
European Journal of Neurology|November 25, 2018
Stroke-like events after brain radiotherapy: a large series with long-term follow-upA L Di Stefano, G Berzero, F Ducray, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2016
Prediction of Response to Temozolomide in Low-Grade Glioma Patients Based on Tumor Size Dynamics and Genetic CharacteristicsP Mazzocco, C Barthélémy, G Kaloshi, et al.
Neurology|January 14, 2009
alpha-Internexin expression identifies 1p19q codeleted gliomasF Ducray, E Crinière, A Idbaih, et al.
Neurology|January 28, 2009
TP53 codon 72 polymorphism is associated with age at onset of glioblastomaS El Hallani, F Ducray, A Idbaih, et al.
Revue Neurologique|March 4, 2014
Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, FranceN Badaoui, D Meyronet, S Cartalat-Carel, et al.
Journal of Neuro-Oncology|August 20, 2013
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapyF Ducray, G Kaloshi, C Houillier, et al.
Revue Neurologique|June 19, 2019
Combined analysis of MGMT methylation and dynamic-susceptibility-contrast MRI for the distinction between early and pseudo-progression in glioblastoma patientsA Bani-Sadr, L P Berner, M Barritault, et al.
Neurology|April 30, 2010
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2M Labussière, A Idbaih, X-W Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2021
The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approachesP Billard, C Guerriau, C Carpentier, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2019
Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma-a randomised multicentre trial (ASTER trial). An ANOCEF studyR Ursu, L Thomas, D Psimaras, et al.
European Journal of Neurology|November 25, 2018
Stroke-like events after brain radiotherapy: a large series with long-term follow-upA L Di Stefano, G Berzero, F Ducray, et al.
Pageof 5